Bluerock Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation For Parkinson'S Disease Cell Therapy Candidate Bemdaneprocel
.Regenerative
Source: menafn.com
Phasei Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Phasei Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Phasei Trial Today - Breaking & Trending Today
CAR T cell therapy for pediatric brain cancer warrants further study
Novel therapeutic approaches are needed for children with diffuse midline glioma (DMG) and other recurrent high-grade central nervous system (CNS) tumors, aggressive brain cancers with poor prognoses. A type of immunotherapy using T cells modified with chimeric antigen receptors (CAR T) has demonstrated efficacy in other cancers, but use in DMG and other CNS tumors has been limited.
Source: medicalxpress.com
AstraZeneca advances scientific leadership in hematology at ASH 2023
CALQUENCE six-year follow-up data reinforce long-term benefit in chronic lymphocytic leukemia, and data across multiple hematology assets showcase breadth of promising early pipeline New,...
Source: marketscreener.com
Gilead and Kite Oncology Present Important New Data Across Multiple Difficult-to-Treat Cancers at ESMO Congress 2023
– Real-World Evidence and New Clinical Analysis Support the Role of Trodelvy® in Metastatic Breast Cancers – – New Data Demonstrate Potential of Trodelvy in Small Cell Lung Cancer,...
Source: marketscreener.com
Cellectis Presents Clinical Data on AMELI-01 and Preclinical Data on Multiplex Engineering for Superior Generation of CAR T-cells at ASGCT 2023
NEW YORK, May 17, 2023 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today presents clinical data... | May 17, 2023
Source: marketscreener.com